Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 8Tumor-Agnostic 3Lymphoid 2Plasma cell 1Other solid neoplasm 1Other neoplasm 1Other 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Neoplasms 2Neoplasm Metastasis 1

Interventions

Paclitaxel 57Gemcitabine 51Carboplatin 51Surveys and Questionnaires 48Docetaxel 37Bevacizumab 37pembrolizumab 33Nivolumab 29Cisplatin 28Fluorouracil 24Capecitabine 23Irinotecan 22Erlotinib Hydrochloride 22Sorafenib 20Leucovorin 19Afatinib 19Radiotherapy 18Pemetrexed 18Oxaliplatin 17Trastuzumab 16Ipilimumab 15regorafenib 14Blood Specimen Collection 14130-nm albumin-bound paclitaxel 14olaparib 13Interviews as Topic 13Cetuximab 13Albumin-Bound Paclitaxel 13atezolizumab 12Sunitinib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Mindfulness × Tumor-Agnostic × Clear all
NCT03557762 2022-05-23

The SEAMLESS Study: Smartphone App-based Mindfulness for Cancer Survivors

University of Calgary

Phase NA Completed
83 enrolled
Tumor-Agnostic

Neoplasms

NCT03446092 2022-05-12

Mindfulness for People With Incurable Cancer

Lancaster University

Phase NA Completed
3 enrolled
Tumor-Agnostic

Neoplasms

NCT03257007 2020-08-12

MEANING

Indiana University

Phase NA Completed
108 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡